Status:
UNKNOWN
Microbiome Analysis in Gastric Intestinal Metaplasia and in Gastric Cancer and Subtypes Correlation
Lead Sponsor:
University Hospital, Ioannina
Collaborating Sponsors:
University of Ioannina
Conditions:
Gastric Intestinal Metaplasia
Gastric Cancer
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of the study will be to analyze the microbiome in the blood and stomach in patients with intestinal metaplasia (IM) and / or gastric cancer (GC). As far as IM is concerned, it has been found t...
Detailed Description
Review of research area Intestinal metaplasia of the stomach (IM) is generally considered a precancerous lesion and is associated with a small increase in the risk of developing gastric cancer (GC). E...
Eligibility Criteria
Inclusion
- Patients with gastric intestinal metaplasia and/or gastric cancer
- Healthy controls
Exclusion
- Metabolic syndrome and its components
- IBD
- Autoimmune diseases
- Otherwise tumours
Key Trial Info
Start Date :
April 18 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04365946
Start Date
April 18 2020
End Date
May 15 2023
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Ioannina
Ioannina, Greece, 45500